Maximize Returns with AI-Powered AUTL Insights



AUTL Forecast

Agenus Unveils Groundbreaking Strategy to Accelerate Registration ... - Best Stocks

August 23, 2023 – Agenus, a renowned biotechnology company, has recently unveiled a groundbreaking strategy aimed at expediting the registration and commercialization of their pioneering BOT/BAL program across various cancer types. This strategic move entails the temporary suspension of all preclinical and clinical initiatives unrelated to BOT/BAL, resulting in a notable reduction of approximately 25% in their workforce. Moreover, Agenus anticipates saving a substantial sum of approximately $40 million by the end of this year.

beststocks.com     Aug 23, 2023